Q32 Bio Inc.
QTTB • Healthcare
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States.
Quality Assessment
Q32 Bio Inc. is a average quality healthcare company with a Compass Score of 46. This stock has mixed fundamentals. Consider carefully and ensure it fits your investment strategy before buying.
Score Breakdown
The Compass Score is based on 6 quality factors identified by academic research.
Click any factor to see detailed metrics
Valuation Metrics
Click any metric for details
Technical Overview
Click any metric for details
Wall Street View
Growth Projections
Financial Health
Click any metric for details
Similar High-Quality Stocks
Important Disclaimer
The Compass Score is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consider consulting a financial advisor before making investment decisions.
Unlock Detailed Metrics
Upgrade to Basic to see the actual financial values behind each quality factor.
- See exact ROA, cash flow ratios, and more
- Unlimited stock lookups
- Export data to CSV
- 7-day free trial included
Cancel anytime